Clinical Trial Update: Clinical Trial Of Neoadjuvant Chemotherapy (NAC)In Upper Tract Urothelial Carcinoma (UTUC) [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant chemotherapy trial in upper tract urothelial carcinoma (and bladder cancer) was terminated, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Cancer

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Urothelial Cancer, Bladder Cancer | Phase 2 | Status: TERMINATED | Results posted: 2014-09-18